ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
-3.99%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$3.53B
AUM Growth
-$528M
(-13%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-9.28%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
1,565
New
259
Increased
499
Reduced
543
Closed
256
Top Buys
| 1 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$366M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$365M |
| 3 |
Emerson Electric
EMR
|
+$26.1M |
| 4 |
Vanguard Energy ETF
VDE
|
+$24.2M |
| 5 |
UnitedHealth
UNH
|
+$16.1M |
Top Sells
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
+$158M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$141M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$138M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$101M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$69.4M |
Sector Composition
| 1 | Technology | 21.26% |
| 2 | Energy | 11.87% |
| 3 | Healthcare | 10.76% |
| 4 | Industrials | 6.89% |
| 5 | Consumer Discretionary | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Landstar System
LSTR
$4.54B
| $92.7K | ﹤0.01% |
524
-3,441
| -87% | -$609K |
|
927
Day One Biopharmaceuticals
DAWN
$759M
| $92.2K | ﹤0.01% |
7,518
-2,895
| -28% | -$35.5K |
|
|
EXAI
928
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $92K | ﹤0.01% |
20,359
+1,305
| +7% | +$5.9K |
|
929
American Homes 4 Rent
AMH
$12.8B
| $92K | ﹤0.01% |
2,730
+130
| +5% | +$4.38K |
|
|
SWTX
930
DELISTED
SpringWorks Therapeutics
SWTX
| $91.9K | ﹤0.01% |
3,973
-999
| -20% | -$23.1K |
|
|
INBX
931
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $91.8K | ﹤0.01% |
5,005
-160
| -3% | -$2.94K |
|
932
Arcus Biosciences
RCUS
$1.2B
| $91.3K | ﹤0.01% |
5,087
-1,888
| -27% | -$33.9K |
|
933
Revolution Medicines
RVMD
$7.65B
| $91.2K | ﹤0.01% |
3,295
-2,262
| -41% | -$62.6K |
|
|
ONC
934
BeOne Medicines Ltd. American Depositary Shares
ONC
$38.6B
| $91.2K | ﹤0.01% |
507
| – | – |
|
935
Lyell Immunopharma
LYEL
$253M
| $91K | ﹤0.01% |
3,096
+909
| +42% | +$26.7K |
|
936
Iovance Biotherapeutics
IOVA
$858M
| $90.3K | ﹤0.01% |
19,857
+3,777
| +23% | +$17.2K |
|
|
AGEN
937
Agenus
AGEN
$162M
| $90.3K | ﹤0.01% |
3,994
+368
| +10% | +$8.32K |
|
938
Royal Caribbean
RCL
$93.8B
| $89.7K | ﹤0.01% |
974
-20,640
| -95% | -$1.9M |
|
939
Zentalis Pharmaceuticals
ZNTL
$115M
| $89.7K | ﹤0.01% |
4,470
-1,184
| -21% | -$23.8K |
|
940
Schrodinger
SDGR
$1.43B
| $89.6K | ﹤0.01% |
3,168
-321
| -9% | -$9.08K |
|
941
RAPT Therapeutics
RAPT
$225M
| $89.2K | ﹤0.01% |
671
-154
| -19% | -$20.5K |
|
942
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.1B
| $89.2K | ﹤0.01% |
+2,569
| New | +$89.2K |
|
943
Teck Resources
TECK
$19.1B
| $89.1K | ﹤0.01% |
2,067
-625
| -23% | -$26.9K |
|
944
Enliven Therapeutics
ELVN
$1.17B
| $88.8K | ﹤0.01% |
6,500
-434
| -6% | -$5.93K |
|
|
IPHA
945
Innate Pharma
IPHA
$188M
| $88.5K | ﹤0.01% |
34,998
-7,433
| -18% | -$18.8K |
|
946
Syndax Pharmaceuticals
SNDX
$1.37B
| $87.5K | ﹤0.01% |
6,028
-1,185
| -16% | -$17.2K |
|
|
MOR
947
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $87.5K | ﹤0.01% |
13,016
-6,271
| -33% | -$42.1K |
|
948
Comcast
CMCSA
$124B
| $87K | ﹤0.01% |
1,963
-3,373
| -63% | -$150K |
|
|
NGM
949
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $85.5K | ﹤0.01% |
79,882
+40,066
| +101% | +$42.9K |
|
950
Caribou Biosciences
CRBU
$171M
| $85.4K | ﹤0.01% |
17,858
-11,210
| -39% | -$53.6K |
|